Diminished origin-licensing capacity specifically sensitizes tumor cells to replication stress. (2013)
Attributed to:
Role of BRCA2 in the response to replication inhibitors
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1541-7786.mcr-12-0491
PubMed Identifier: 23364533
Publication URI: http://europepmc.org/abstract/MED/23364533
Type: Journal Article/Review
Volume: 11
Parent Publication: Molecular cancer research : MCR
Issue: 4
ISSN: 1541-7786